The short version
12 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Ipratropium Bromide
Ipratropium Bromide · IPRATROPIUM BROMIDE .5 mg/2.5mL · Solution · Respiratory (Inhalation) · Cardinal Health 107, LLC
NDC 55154-4411-05 · 5 POUCH in 1 BAG / 1 AMPULE in 1 POUCH / 2.5 mL in 1 AMPULE · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 00487-9801-25) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$0.1217per unit
middle half $0.1088–$0.1647 · 5,496 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.1217
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
100%of plans cover it
tier 2 · prior auth 100% · step therapy 0% · qty limit 4%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.2%chance of a new FDA shortage posting for ipratropium bromide (other) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA075693
- TE code
- AN
- Approval date
- Jan 26, 2001
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Ipratropium Bromide (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Cardinal Health 107, LLC | IPRATROPIUM BROMIDE .5 mg/2.5mL | Jul 15, 2026 | Sep 3, 2026 |
| American Health Packaging | IPRATROPIUM BROMIDE .5 mg/2.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | IPRATROPIUM BROMIDE .5 mg/2.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Chartwell RX, LLC | IPRATROPIUM BROMIDE .5 mg/2.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals Inc. | IPRATROPIUM BROMIDE .5 mg/2.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Nephron Pharmaceuticals Corporation | IPRATROPIUM BROMIDE .5 mg/2.5mL | Jul 15, 2026 | Sep 2, 2026 |
| NuCare Pharmaceuticals, Inc. | IPRATROPIUM BROMIDE .5 mg/2.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Redpharm Drug | IPRATROPIUM BROMIDE .5 mg/2.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | IPRATROPIUM BROMIDE .5 mg/2.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Ritedose Pharmaceuticals, LLC | IPRATROPIUM BROMIDE .5 mg/2.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | IPRATROPIUM BROMIDE .5 mg/2.5mL | Jul 15, 2026 | Sep 2, 2026 |
| A-S Medication Solutions | IPRATROPIUM BROMIDE .5 mg/2.5mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Ipratropium Bromide — NDC 55154-4411-05," retrieved September 3, 2026, https://drugdashboards.com/drug/55154441105.
Free to cite with attribution — see how the data is put together.